Fiduciary Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Buy
11,681
+874
+8% +$893K 0.95% 17
2026
Q1
$9.78M Buy
10,807
+536
+5% +$543K 0.59% 45
2025
Q4
$11M Sell
10,271
-300
-3% -$287K 0.72% 29
2025
Q3
$8.07M Buy
10,571
+318
+3% +$237K 0.54% 42
2025
Q2
$7.99M Buy
10,253
+2,954
+40% +$2.3M 0.6% 40
2025
Q1
$6.03M Buy
7,299
+1,112
+18% +$925K 0.59% 42
2024
Q4
$4.78M Buy
6,187
+2,460
+66% +$2.04M 0.48% 58
2024
Q3
$3.3M Buy
3,727
+3,004
+415% +$2.7M 0.44% 59
2024
Q2
$656K Buy
723
+416
+136% +$333K 0.11% 108
2024
Q1
$234K Buy
+307
New +$218K 0.04% 171
2023
Q3
Sell
-278
Closed -$130K 611
2023
Q2
$130K Buy
+278
New +$117K 0.03% 183
2023
Q1
Sell
-266
Closed -$97.3K 543
2022
Q4
$97.3K Buy
+266
New +$94.3K 0.03% 167

Other funds holding LLY

Fiduciary Alliance's LLY Position: Q2 2026 in Review

Fiduciary Alliance increased its Eli Lilly (LLY) stake by 8.1% in Q2 2026, buying an estimated $893K and bringing the position to 11,681 shares worth $14M. The position accounts for 0.95% of the portfolio, ranked #17.

Fiduciary Alliance first reported a position in LLY in Q4 2022 and has held it in 12 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fiduciary Alliance held 11,681 shares of Eli Lilly worth $14M as of Q2 2026.
  • Fiduciary Alliance bought 874 Eli Lilly shares in Q2 2026, an estimated $893K.
  • Eli Lilly made up 0.95% of Fiduciary Alliance's portfolio in Q2 2026, its #17 holding.
  • Fiduciary Alliance first reported a position in Eli Lilly in Q4 2022 and has held it in 12 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.